Resolution criteria

This market will resolve to YES if, by December 31, 2028, any of the following occur:

1. The FDA (or equivalent major medical regulatory body) grants clearance or approval to the Midjourney Scanner (or Midjourney Medical scanner) with documentation explicitly stating its imaging resolution or diagnostic performance is superior to standard 1.5T or 3T MRI machines for full-body scanning.

2. A peer-reviewed clinical study published in a major imaging journal (e.g., Radiology, Journal of Magnetic Resonance Imaging, or The Lancet) concludes that the Midjourney Scanner achieves superior spatial resolution, contrast resolution, or overall diagnostic quality compared to a standard 1.5T MRI.

3. There is a broad consensus among professional medical imaging societies (such as the Radiological Society of North America - RSNA) declaring its imaging quality to be superior to standard MRIs.

If no such official regulatory declaration, peer-reviewed clinical study, or expert consensus has verified superior quality/resolution over a standard 1.5T or 3T MRI by December 31, 2028, this market will resolve to NO.

The primary sources for verification will be the FDA Devices Database, publications in Radiology, or official press releases from Midjourney Medical and reputable medical science outlets.

Background

On June 17, 2026, Midjourney founder David Holz announced "Midjourney Medical" and its first hardware project, the Midjourney Scanner. Unlike traditional MRI machines, which use heavy magnets and take up to 90 minutes, the Midjourney Scanner is a water-immersion device utilizing approximately 358,000 ultrasonic sensors (built on Butterfly Network's ultrasound-on-chip technology) to perform a full-body scan in just 60 seconds.

Holz claimed that the scanner is "in many ways superior to even MRI machines" and aims to deliver comparable or superior image quality without radiation or magnets. However, practicing radiologists have pointed out that ultrasound has inherent physical limitations (such as an inability to reliably penetrate bone or image air-filled organs like lungs), making full-body diagnostic parity with MRIs a significant engineering hurdle. Midjourney plans to focus initially on body composition mapping at a "Midjourney Spa" concept targeted to open in San Francisco in 2027, with diagnostic FDA clearances planned as a long-term goal.